Polo-like kinases (Plks) are prognostic markers for gynecologic malignancies

Current Women's Health Reviews

Volumn 4, Issue 4, 2008, Pages 266-269

  Takai, Noriyuki ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Ovarian cancer; Polo like kinases

Indexed keywords

(3 HYDROXYISOVALERYL)SHIKONIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLINE; KI 67 ANTIGEN; POLO LIKE KINASE; POLO LIKE KINASE 1; POLO LIKE KINASE 2; POLO LIKE KINASE 3; PROTEIN KINASE INHIBITOR; SCYTONEMIN; SHIKONIN DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG TARGETING; ENDOMETRIUM CARCINOMA; ENZYME INHIBITION; FEMALE; GYNECOLOGIC CANCER; HUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE;

EID: 60649093335     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340408786848179     Document Type: Review

References (42)

1. Hamanaka R, Maloid S, Smith MR, O'Connell CD, Longo DL, Ferris DK. Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell Growth Differ 1994; 5: 249-57.
2. Glover DM, Hagan IM, Tavares AA. Polo-like kinases: a team that plays throughout mitosis. Genes Dev 1998; 12: 3777-87.
3. Lee KS, Grenfell TZ, Yarm FR, Erikson RL. Mutation of the polobox disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc Natl Acad Sci USA 1998; 95: 9301-6.
4. Lee KS, Song S, Erikson RL. The polo-box-dependent induction of ectopic septal structures by a mammalian polo kinase, plk, in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1999; 96: 14360-5.
5. Hamanaka R, Smith MR, O'Connor PM, et al. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem 1995; 270: 21086-91.
6. Glover DM, Ohkura H, Tavares A. Polo kinase: the choreographer of the mitotic stage? J Cell Biol 1996; 135: 1681-4.
7. Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol 1996; 135: 1701-13.
8. Nigg EA. Polo-like kinases: positive regulators of cell division from start to finish. Curr Opin Cell Biol 1998; 10: 776-83.
9. Llamazares S, Moreira A, Tavares A, et al. Polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes Dev 1991; 5: 2153-65.
10. Fenton B, Glover DM. A conserved mitotic kinase active at late anaphase-telophase in syncytial Drosophila embryos. Nature 1993; 363: 637-40.
11. Kumagai A, Dunphy WG. Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts. Science 1996; 273: 1377-80.
12. Descombes P, Nigg EA. The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts. EMBO J 1998; 17: 1328-35.
13. Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, Strebhardt K. Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol 1997; 150: 1165-72.
14. Kotani S, Tugendreich S, Fujii M, et al. PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol Cell 1998; 1: 371-80.
15. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21-32.
16. Shimizu S, Osada H. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nat Cell Biol 2000; 2: 852-4.
17. Lee M, Daniels MJ, Venkitaraman AR. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. Oncogene 2004; 23: 865-72.
18. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000; 2: 672-6.
19. vanVugt MA, Smits VA, Klompmaker R, Medema RH. Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion. J Biol Chem 2001; 276: 41656-60.
20. Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol2001; 21: 3853-61.
21. Smith MR, Wilson ML, Hamanaka R, et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 1997; 234: 397-405.
22. Fisher RAH, Ferris DK. Curr Med Chem 2002; 2: 1-10.
23. Li B, Ouyang B, Pan H, et al. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas. J Biol Chem 1996; 271: 19402-8.
24. Dai W, Li Y, Ouyang B, et al. PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer. Genes Chromosomes Cancer 2000; 27: 332-6.
25. Dai W, Liu T, Wang Q, Rao CV, Reddy BS. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 2002; 20: 121-6.
26. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett 2001; 164: 41-9.
27. Weichert W, Denkert C, Schmidt M, et al. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer 2004; 90: 815-21.
28. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Polo-like kinase (PLK) expression in endometrial carcinoma. Cancer Lett 2001; 169: 41-9.
29. Elez R, Piiper A, Giannini CD, Brendel M, Zeuzem S. Polo-like kinase1, a new target for antisense tumor therapy. Biochem Biophys Res Commun 2000; 269: 352-6.
30. Mundt KE, Golsteyn R, Lane HA, Nigg EA. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 1997; 239: 377-85.
31. Conn CW, Hennigan RF, Dai W, Sanchez Y, Stambrook PJ. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res 2000; 60: 6826-31.
32. Yuan J, Kramer A, Eckerdt F, Kaufmann M, Strebhardt K. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation. Cancer Res 2002; 62: 4186-90.
33. Cogswell JP, Brown CE, Bisi JE, Neill SD. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. Cell Growth Differ 2000; 11: 615-23.
34. Liu X, Erikson RL. Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc Natl Acad Sci USA 2002; 99: 8672-6.
35. Liu X, Erikson RL. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 2003; 100: 5789-94.
36. Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst 2002; 94: 1863-77.
37. Stevenson CS. Proceeding of 90th American Association for Cancer Research, Washington DC. 1999.
38. Dietzmann K, Kirches E, von Bossanyi P, Jachau K, Mawrin C. Increased human polo-like kinase-1 expression in gliomas. J Neurooncol 2001; 53: 1-11.
39. Masuda Y, Nishida A, Hori K, et al. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene 2003; 22: 1012-23.
40. Takai N, Yoshimatsu J, Nishida Y, Narahara H, Miyakawa I, Hamanaka, R. Expression of polo-like kinase (PLK) in the mouse placenta and ovary. Reprod Fertil Dev 1999; 11: 31-5.
41. Yoshimatsu J, Takai N, Yoshimatsu Y, Narahara H, Miyakawa I, Hamanaka R. Immunohistochemical localization of polo like kinase in early human placenta. Res Commun Mol Pathol Pharmacol 1999; 106: 3-12.
42. Takai N, Miyazaki T, Miyakawa I, Hamanaka R. Polo-like kinase expression in normal human endometrium during the menstrual cycle. Reprod Fertil Dev 2000; 12: 59-67.